This fact sheet examines the key role played by the United States in the Global Fund, an independent, multilateral financing entity designed to raise significant new resources to combat HIV/AIDS, tuberculosis (TB), and malaria in low- and middle- income countries.
- view as grid
- view as list
This updated fact sheet highlights the epidemic’s impact on Black Americans, providing current data and trends over time. Black Americans have been disproportionately affected by HIV/AIDS since the epidemic’s beginning, and that disparity has deepened over time. Blacks account for more new HIV diagnoses, people estimated to be living with HIV, and HIV-related deaths than any other racial/ethnic group in the U.S.
This fact sheet provides an overview of the Ryan White Program, the largest HIV-specific federal grant program in the United States.
This updated fact sheet provides the latest data on the U.S. HIV epidemic, including key trends over time, impact by region and population, and information on the U.S. government’s response.
This fact sheet looks at the history, funding, and future outlook of the President’s Emergency Plan for AIDS Relief (PEPFAR), the U.S. government’s major global initiative to combat HIV/AIDS.
This fact sheet provides an overview of U.S. government global health policy and engagement.
This updated fact sheet provides the latest data on the global HIV/AIDS epidemic, including impact by region, treatment and prevention efforts, and an overview of the U.S. and global responses to the epidemic.
This fact sheet provides information on key HIV testing statistics, testing recommendations as advised by the U.S. Centers for Disease Control and Prevention (CDC), insurance coverage of HIV testing, testing sites and policies, and types of tests available.
This fact sheet provides an updated overview of federal funding for HIV/AIDS, highlighting key domestic and global HIV/AIDS programs and comparisons over time.
This fact sheet provides current information about state AIDS Drug Assistance Programs (ADAPs), which provide HIV medications to low-income people with HIV/AIDS who have limited or no prescription drug coverage.